Anil kumar

Anil kumar

Tutor and Researcher

Department of Microbiology, Shree Gorakhnath Medical College Hospital and Research Centre, Mahayogi Gorakhnath University Gorakhpur Uttar Pradesh India

Profile ID RP-003-8758 Joined 2026-03-06 8 articles
0Connections
3
Total Views
8
Total Publications
238
Publication Views

About me

Anil Kumar is a researcher in the field of Medical Microbiology and currently serves as a Tutor in the Department of Microbiology at Shree Gorakhnath Medical College Hospital and Research Centre, Mahayogi Gorakhnath University, Gorakhpur, Uttar Pradesh, India. He is also a PhD scholar in Medical Microbiology at Mahayogi Gorakhnath University, Gorakhpur. He completed his B.Sc. in Medical Microbiology from Chhatrapati Shahu Ji Maharaj University, Kanpur and M.Sc. in Medical Microbiology from Integral University, Lucknow. His research interests focus on clinical microbiology, antimicrobial resistance (AMR), bacteriological profiling of infectious diseases, and antibiotic susceptibility patterns of clinical isolates. His work emphasizes the detection and characterization of multidrug-resistant organisms such as ESBL and MBL producing bacteria. His research aims to contribute to improved diagnostic strategies, infection control, and antimicrobial stewardship to combat the increasing threat of antibiotic resistance in healthcare settings.

Articles(8)

Authors: Anil Kumar, Anjali Singh, Aniruddha Sen

DOI: 10.1007/978-3-031-40858-8_584-2

Volume2025
Issue2025
Pages1-9
Abstract

Antimicrobial resistance (AMR) is a pressing global health crisis that disproportionately affects pediatric populations, particularly children with disabilities. This entry explores the intricate relationship between AMR and childhood disability, emphasizing how repeated infections, extended hospitalizations, frequent exposure to antibiotics, and compromised immunity exacerbate the vulnerability of this group. Children with neurodevelopmental disorders, birth defects, or physical impairments often encounter multidrug-resistant organisms, which lead to increased morbidity, mortality, and long-term functional impairments. AMR not only complicates treatment outcomes but also delays developmental milestones, impacts educational and social integration, and poses significant psychosocial and economic burdens on families and caregivers. This entry highlights key mechanisms through which AMR contributes to pediatric disability, including recurrent or untreated infections, nosocomial complications, delayed diagnosis, and iatrogenic harm from toxic second-line antibiotics. It also addresses the compounded risks in low-resource settings where poor hygiene, over-the-counter antibiotic use, and limited diagnostic tools amplify resistance trends. In response, this entry proposes a comprehensive, multisector mitigation strategy involving pediatric antibiotic stewardship, vaccination programs, public education, inclusive policy frameworks, and innovations in diagnostics and therapeutics. Anchored in the One Health paradigm, it advocates for AMR strategies that explicitly recognize and prioritize children with disabilities. Through a synthesis of epidemiological insights and policy imperatives, this entry aims to inform stakeholders and guide equitable interventions that reduce health disparities and improve the quality of life for affected children worldwide.

Authors: Alok, Mahendra Prasad Verma, Rahul Singh Raghuvanshi, Shiwali Dhiman, Anil Kumar, Bhavna Sharma, Penkey Yeliya, Lokesh Ramachandran

DOI: 10.56557/upjoz/2025/v46i235381

Volume46
Issue23
Pages21-40
Abstract

Plant diseases continue to pose significant threats to global agricultural productivity, food security, and ecosystem stability. The review aims to explore the application of plant extracts and natural compounds in plant disease control. The overreliance on synthetic chemical pesticides has led to severe environmental consequences, including soil and water contamination, non-target organism toxicity, and the emergence of resistant pathogen strains. Plant extracts and natural compounds have emerged as viable alternatives for plant disease management due to their biodegradability, low toxicity, and broad-spectrum antimicrobial properties. These botanicals, derived from medicinal, aromatic, and agro-waste plants, contain bioactive constituents such as alkaloids, flavonoids, terpenoids, and phenolics that exhibit antibacterial, antifungal, antiviral, and nematicidal effects. Various extraction and formulation techniques, ranging from crude preparations to nanoencapsulation, have enhanced the efficacy and stability of these compounds under field conditions. Mechanistically, they operate through multiple pathways, including disruption of microbial cell structures, inhibition of spore germination, and induction of plant immune responses such as systemic acquired resistance (SAR) and induced systemic resistance (ISR). Numerous laboratory and field studies have validated their effectiveness against pathogens such as Fusarium, Botrytis, Xanthomonas, and Pseudomonas, showing comparable performance to conventional pesticides. Despite their potential, limitations such as phytochemical variability, short shelf life, regulatory hurdles, and lack of standardisation restrict their widespread adoption. Recent advances in biotechnology, controlled-release systems, and integration with microbial biocontrol agents have opened new avenues for their application. Moreover, their compatibility with organic farming and precision agriculture systems supports their role in sustainable crop protection. This review highlights the current applications, mechanisms, innovations, and challenges associated with plant-based disease control, while emphasising future research directions and policy frameworks needed to enhance their adoption. Strengthening interdisciplinary collaborations, farmer training, and regulatory support can pave the way for the next generation of green pesticides that are both effective and environmentally responsible. With strategic implementation and innovation, plant-based disease control methods can play a transformative role in future agroecological systems and integrated pest management frameworks.

Authors: Anil Kumar, Ankita Sharma, Katiyar Iva, Sen Aniruddha

DOI: 10.1007/978-3-031-40858-8_586-1

Volume2025
Issue2025
Pages1-8
Abstract

Climate change poses unprecedented threats to child health, with environmental shifts expanding the range of climate-sensitive infectious diseases. This entry examines how rising temperatures and altered precipitation patterns increase transmission of vector-borne diseases like malaria, dengue, Zika, and chikungunya, disproportionately affecting children due to their developing immune systems and higher vulnerability. Beyond acute illness, climate-exacerbated infections create significant disability risks through neurological complications from congenital Zika syndrome, cerebral malaria, and viral encephalitis, resulting in developmental delays and cognitive impairments. Sensory deficits from infections like cytomegalovirus and rubella represent additional long-term consequences often overlooked in climate health discussions. This entry explores essential adaptive strategies including enhanced surveillance systems integrating climate data, climate-resilient vaccination programs, and community-based health education. Policy recommendations emphasize multi-sectoral approaches aligning climate action with child health protection through disability-inclusive planning and global collaboration. This entry underscores urgent needs for proactive interventions safeguarding children’s health rights. The intersection of climate change, infectious diseases, and childhood disability demands coordinated responses prioritizing vulnerable populations, particularly in low- and middle-income countries where social determinants amplify climate health risks.

Authors: Dr Rajini Uday, Dr Diya Shah, Dr Ashwini Nayak U, Dr Honnareddy Sanjota, KB Yuktha, K Syed Ali Munavar

DOI: 10.36106/ijsr

Volume13
Issue9
Pages42-44
Abstract

Aim And Background: Posterior Reversible Encephalopathy Syndrome (PRES) is a medical enigma that lies at the intersection of neurology and obstetrics. First described by Hinchey et al. in 1996, PRES is marked by a dramatic constellation of symptoms: severe headache, seizures, visual disturbances, and altered mental status. The pathophysiology of PRES is as complex as its presentation, often involving a breach in the blood-brain barrier precipitated by acute hypertension or endothelial dysfunction leading to characteristic edema, predominantly affecting the parieto-occipital regions of the brain. In this context, we delve into the case of a 19-year-old primigravida, whose journey through the triple challenges of Pre- Eclampsia, HELLP syndrome, and PRES exemplies the essence of resilient motherhood. By exploring her case, we aim to shed light on the critical importance of early recognition and comprehensive management of PRES in pregnancy, ensuring better outcomes. Case Description: A 19 year old primigravida at 26 weeks of gestation presented with preeclampsia with severe features, with impending eclampsia with HELLP syndrome. She experienced bilateral lower limb weakness postpartum. Based on clinical examination and radiological imaging, she was diagnosed with PRES. Management included blood pressure control using intravenous and oral antihypertensives, anticonvulsant and neuroprotective agents. Supportive care was provided, including close monitoring of neurological status. The multidisciplinary approach involved obstetricians, neurologists, and intensive care specialists, ensuring comprehensive care. Recovery was uneventful with scheduled followup. This Conclusion: case underscores the critical importance of early detection of PRES in pregnant women with preeclampsia. Prompt diagnosis through clinical assessment and radiological imaging is vital for initiating appropriate treatment and averting serious complications. Although the development of PRES involves various mechanisms, effective management primarily focuses on controlling hypertension and addressing the root cause. With timely intervention, the prognosis is generally positive, but additional research is needed to thoroughly understand the pathophysiological processes and rene treatment protocols. Understanding PRES is vital because it can be reversible i Clinical Significance: f treated promptly. With diverse range of symptoms, often associated with elevated blood pressure- pregnant women with preeclampsia are at risk. Early detection through clinical assessment and radiological imaging followed by proper management can prevent severe complications, signicantly improving patient prognosis. Recognising PRES helps distinguish it from other neurological disorders, ensuring precise diagnosis and appropriate treatment, thus enhancing patient care quality. This case highlights the critical management of severe preeclampsia and the necessity of a coordinated multidisciplinary approach. The timely intervention was essential in managing maternal and fetal outcomes. The transient lower limb weakness post-delivery was notable, underscoring the importance of thorough neurological assessment in such cases. Severe preeclampsia with HELLP syndrome and IUGR presents signicant management challenges requiring prompt and comprehensive care. This case emphasizes the importance of vigilant monitoring and multidisciplinary strategies to prevent adverse outcomes.

Authors: Priya Chauhan, Areena Hoda Siddiqui, Anil Kumar, Naimshree Sonkar

DOI: 10.51470/bca.2024.24.1.775

Volume24
Issue1
Pages775
Abstract

Mycoses, or fungal infections are a serious health concern for people because of its increasing rates of morbidity and mortality, they have become a global source of worry for medical practitioners. An estimated one billion people are affected by fungal infections annually and they cause 1.6 million deaths. Most fungal pathogen-induced human infections are caused by species of Candida. These species include Candida albicans, resulting in opportunistic infections; drug-resistant Candida glabrata; Candida auris, the new danger to global public health; and other developing species including tropicalis, parapsilosis and krusei. Candida albicans is a commensal yeast fungus in oral, gastrointestinal, genital mucosal surfaces and skin. It is the commonest fungus microbiome in humanbeing; it asymptomatically colonises various regions of the body, particularly the gastro intestinal and genitour inary tracts of healthy people. Changes in the microbiota of the host, stress and host immunity can all contribute to the overgrowth of Candida albicans, which can result in a variety of illnesses, ranging from superficial mucosal infections to hematogenously disseminated candidiasis. The majority of research on Candida albicans has been done in suspension cultures thus far, but the medical significance of this bacteria and other microorganisms--relies on its capacity to proliferate as a biofilm, or densely packed community of cells. Biofilms being well known for growing on implanted medical equipment, such as pacemakers, prosthetic joints and catheters, which offer surfaces and havens for biofilm development. Because C. albicans biofilms are inherently resist ant in the host immune system, traditional antifungal medications and other environmental perturbations, biofilm-based infections pose a serious clinical issue. This review aims to discuss the Biofilm Formation Mechanism in Candida albicans with Special Reference to its Virulence Factors.

Authors: Alka Kushwaha, Anil Kumar, Aman Sharma

DOI: 10.21275/sr25916213348

Volume14
Issue9
Pages755-760
Abstract

Abstract: Urinary tract infections are among the more frequent bacterial illnesses observed in clinical settings worldwide. Any component of the urinary system can get infected with a urinary tract infection (UTI). Mostly infections affect the lower urinary system, especially the urethra and bladder. A UTI is more common in women than in males. If the infection is limited to the bladder, it may be uncomfortable and bothersome. Material and Methods: A total of 156 samples were obtained from patients exhibiting clinical indications of UTI at a tertiary care hospital in Gorakhpur. Standard microbiological procedures were used to isolate and identify microorganisms. Antibiotic susceptibility testing was carried out using the Kirby-Bauer disc diffusion technique in accordance with CLSI guidelines. Results: Out of the 156 samples tested, 66 (42.30%) showed bacterial growth, 11 (7.05%) showed fungal growth, and 79 (50.64%) were culture-negative. E. coli antibiotic susceptibility patterns revealed a troubling trend of multidrug resistance, particularly with commonly used antibiotics such as ampicillin, ciprofloxacin, and third-generation cephalosporin’s. Conclusion: The findings of this study highlight the necessity of continual observation of uropathogens, as well as their resistance patterns, in guiding appropriate empirical therapy. Such data are critical for developing antibiotic stewardship strategies to tackle the growing issue of antimicrobial resistance in community and hospital settings. Keywords: Urinary tract infection, Bacterial spectrum, Antibiotic resistance, Uro pathogens, E. coli, tertiary care hospital

Authors: Anjali Singh, Anil Kumar

DOI: 10.21275/sr25930082238

Volume14
Issue9
Pages1517-1526
Abstract

One of the most prevalent ailments afflicting people worldwide, particularly in underdeveloped nations, is respiratory tract infection (RTI). Public health and the results for patients are seriously threatened by the increasing prevalence of resistant bacteria to antibiotics among the bacterial infections that cause RTIs. The purpose of this study is to ascertain the pattern of antibiotic resistance and bacteriological profile of RTI patients who are admitted to a hospital with tertiary care. Material & Methods: 92 patients with a clinical suspicion of RTI participated in a prospective trial. Clinical samples were collected and processed according to standard microbiological protocols. The isolated pathogenic microbes were identified by biochemical testing, and in accordance with CLSI standards, the Kirby-Bauer disc diffusion technique was employed to test them for antibiotic susceptibility. Result: Out of 92 samples, 50 (54.35%) were culture-negative, 3 (3.26%) had fungal growth, and 39 (42.39%) had bacterial growth. Klebsiella species, Pseudomonas aeruginosa, E. coli, Acinetobacterbaumannii and Staph. Aureus, among others, were the most common bacterial isolates. High resistance to ceftazidime (83.33%) & aztreonam (83.33%) was found in Klebsiella isolates, with piperacillin (66.66%) and tigecycline as (58.33%) following closely behind. Conclusion: The study shows that multidrug-resistant organisms, especially Klebsiella spp., are quite common in RTI cases. For efficient care and to direct empirical therapy, it is essential to regularly evaluate bacterial trends and patterns of antibiotic susceptibility. Strict infection control procedures and the prudent use of antibiotics are required to counteract the growing threat of resistance to antibiotics. Keywords: Respiratory tract infections, Antibiotic resistance, Antibiotic sensitivity, Tertiary care hospital, Bacterial profile

Authors: Anil Kumar, Anjali Singh, Abhilasha Devi, Vikas Kumar Yadav, Akhilesh Kumar Dubey

DOI: 10.55248/gengpi.6.0925.3557

Volume6
Issue9
Pages5063-5076
Abstract

Soil fungi are one of the most prevalent and functionally significant categories of organisms in soil ecosystems, with between 2 and 3 million species found worldwide, only a small percentage of which have been formally documented. These include dangerous bacteria that can infect humans, animals, and plants, as well as collaboratively advantageous microbial populations such filamentous organisms and aerobic decomposers. Because of their many functions, soil fungus can be both advantageous ecosystem engineers and possible disease pathogens. They are necessary for the breakdown of organic matter, the production of humus, the cycling of nutrients, and the preservation of soil fertility. Through productive partnerships, they also aid in the production of carbon and oxygen and positively impact plant growth. However, the importance of environmental diseases in ecology and medicine is highlighted by the fact that they result in large losses in agriculture and that newly identified human illnesses are brought on by pathogenic bacteria that are common in soil. Recent advances in molecular phylogenetics, metagenomics, and next-generation sequencing have revolutionized the study of fungal diversity and pathogenicity, enabling the discovery of cryptic lineages and the restructuring of fungal taxonomy. Functional ecology approaches have shown that the interactions of fungal communities are intricate, resilient to environmental disturbances, and contribute to ecosystem services. Traditional taxonomy and molecular techniques have been used to highlight the ever-changing balance between beneficial and harmful soil fungi and to shed light on evolutionary relationships. This chapter summarizes the previously discussed taxonomic classification, ecological functions, diversity of functions, and pathogenic potential of soil fungus as well as their usefulness in agriculture, biotechnology, environmental management, and medical mycology. Currently discussed topics include the development of antifungal drug resistance, the impact of global warming on fungal populations, and the need for integrative approaches to understand their pathogenic and ecological components. This review bridges ecological, taxonomic and clinical perspectives to highlight the dual character of soil fungus as possible dangers to world nutritional well-being and as essential ecosystem regulators. Keywords: Molecular taxonomy, Functional ecology, Biodiversity, Mycorrhizae, Pathogenicity, Decomposition

No matching articles

Try another word from the title, author or DOI.

Brief Bio

Anil Kumar is a researcher in the field of Medical Microbiology and currently serves as a Tutor in the Department of Microbiology at Shree Gorakhnath Medical College Hospital and Research Centre, Mahayogi Gorakhnath University, Gorakhpur, Uttar Pradesh, India. He is also a PhD scholar in Medical Microbiology at Mahayogi Gorakhnath University, Gorakhpur. He completed his B.Sc. in Medical Microbiology from Chhatrapati Shahu Ji Maharaj University, Kanpur and M.Sc. in Medical Microbiology from Integral University, Lucknow. His research interests focus on clinical microbiology, antimicrobial resistance (AMR), bacteriological profiling of infectious diseases, and antibiotic susceptibility patterns of clinical isolates. His work emphasizes the detection and characterization of multidrug-resistant organisms such as ESBL and MBL producing bacteria. His research aims to contribute to improved diagnostic strategies, infection control, and antimicrobial stewardship to combat the increasing threat of antibiotic resistance in healthcare settings.

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Scholars in the same field

SD
Snehal dinesh borana
0 publications
HK
Dr Harnoor kaur
0 publications
SN
Shikha Naagar
0 publications
AA
Aastha Ahuja
0 publications
NN
Nilam Navinbhai Pala
0 publications
SR
Sharif Ratul Hassan
Northern University Bangladesh
0 publications
MN
Mohammad Nasir
0 publications
AR
Ananta Raj Sharma
0 publications

Following

Nobody here yet.

Followers

Nobody here yet.

8 Publications